Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Safety data from trials In a paper summarizing 6 randomized, double-blind, placebo-controlled human trials, AOD 9604 did not significantly affect IGF-1 levels, did not impair glucose tolerance, and no serious adverse events (SAEs) were attributed to AOD 9604
BPC-157 TB-500 Side Effects & Safety BPC-157 Generally very well tolerated in research models Minimal reported side effects at standard doses No significant hormonal impact Theoretical concern: may promote angiogenesis in existing tumors (same as any pro-angiogenic compound) TB-500 Well tolerated
Online Grey-Market Peptides Typically labeled "for research use only," though clearly marketed for human use
BPC-157 does not interact with hormone receptors in the same way as steroids or SARMs, and it does not share their chemical structure or mechanism
Our team strongly advises against it
Cross-border purchasing may involve customs considerations depending on source location and shipment documentation
US$ 25.03
US$ 29.12
US$ 26.46
US$ 26.83
US$ 24.97
US$ 28.04